Drug Profile
1-Amino-5-bromouracil
Alternative Names: ABULatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Yamasa Corporation
- Class Anxiolytics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 16 Jun 1996 Discontinued-Preclinical for Anxiety disorders in Japan (Unknown route)